Circle Birmingham - drone video

This process has two main components.

If these additional modular construction costs can be offset by large improvements in construction site efficiency, for example by relocating wet trades or complex specialist trades away from the site, a 3D module might make sense.But, with modular construction, it’s often the case that prefabricating comparatively simple parts of a building as 3D modules adds cost and complexity, especially if the required trades need to be present on-site anyway..

The problems found in modular construction are only compounded by inefficient factory working.The cost of any prefabricated component (indeed, any component of any building) can be divided into materials and labour.If we ignore the cost of the labour that has gone into making the component, we only have material costs left, resulting in limited opportunities to add value.

Manufacturers have understood this for decades and spent a great deal of effort developing highly productive assembly routines that enabled the mass production, automation and commoditisation that fuelled the consumer age.. Too often factories are treated as ‘construction sites in a shed' producing bespoke, custom components with overlapping trades and poor works sequencing, causing reduced value and the same inefficiencies that are often found on construction sites.We want the factories that produce components for the construction industry to be more like the best factories making consumer goods; highly efficient, controlled and focused on achieving the highest throughput for the lowest cost, without compromising on quality..

In short, we want factories to be less like construction sites.. Construction Platforms: our MMC approach to achieving the best mix of on-site and off-site construction.

At Bryden Wood, we have over 25 years’ experience applying all types of MMC solutions to a huge range of projects.The Singapore API plant is the 2024 FOYA Category Winner for Operations, Project Execution.

This is thanks to the whole project team's successful delivery of a large and complex project ahead of schedule and under budget during a global pandemic.. GSK Parma Attachment Inhibitor: meeting a life-saving need.Aiming to introduce manufacturing capability into GSK’s Parma site for Fostemsavir (a life-saving HIV drug for patients with limited or no other treatment options available), this project’s brief was ambitious.. To maintain supply while the drug was in development and clinical trials, GSK had to build and commission a brand new facility in a shorter timeframe than had ever been achieved before.. As lead designer, Bryden Wood formed a collaborative team with external partners and client representatives to capture functional requirements in “Chip” models that could be rapidly configured to allow many design options to be evaluated in a short time..

The ability to undertake rapid digital optioneering was particularly important as forecast demand volumes were uncertain and clinical manufacturing requirements for the drug were still being developed during the design phase.We developed a capacity model in-house to inform decisions around unit operations and scale..